WebMar 27, 2024 · Looking ahead for fiscal 2024, estimated BioNTech COVID-19 vaccine revenues would be around 5 billion euros. BioNTech said the revenue estimate reflects expected revenues related to its share of gross profit from COVID-19 vaccine sales in the collaboration partner's territories, and from direct COVID-19 vaccine sales to customers … WebJan 5, 2024 · BioNTech’s Q3 2024 commercial COVID-19 revenues included an estimated amount of €4.34 billion gross profit share and €17.0 million worth of sales milestones …
Annual revenue BioNTech 2024-2024 Statista
WebNov 7, 2024 · (RTTNews) - German biotechnology company BioNTech SE (BNTX) reported Monday that its third-quarter net profit declined to 1.78 billion euros from last year's 3.21 … WebDec 31, 2024 · Annual Financial Statements of BioNTech SE, Mainz, December 31, 2024. In case of deviations of the English version of this document from the German version, the German version shall prevail. Statements of Financial Position. 2. … jeff tedford health
BioNTech profits soar in 2024 on global vaccine rollout - Medical Xpress
WebAug 9, 2024 · German pharmaceutical maker BioNTech, which developed the first widely used coronavirus vaccine with Pfizer, swung to a huge profit in the second quarter on record sales, with far more forecast to ... WebMar 27, 2024 · BioNTech’s 2024 revenues dropped compared to the year prior due to declining demand for the COVID-19 vaccine it developed with Pfizer, the company announced Monday in its earnings report.. BioNTech reported fourth quarter net profit of €2.28 billion, or $2.45 billion, a drop from €3.1 billion, or about $3.3 billion, in the same … WebNov 10, 2024 · The US drugmaker Pfizer and the German biotech firm BioNTech stand to bring in nearly $13bn (£9.8bn) in global sales from their coronavirus vaccine next year, which will be evenly split between ... oxford stinger disc lock